Benefits of Tomosynthesis in Daily Practice
Annual mammography screening can save lives because breast cancer is a progressive disease and early detection enables improved prognosis due to appropriate treatment of small non-palpable node-negative cancers. Multiple randomized controlled trials and observational studies have shown that mammography can reduce breast cancer mortality by 30% or more.
Digital breast tomosynthesis (DBT) was approved by the Food and Drug Administration (FDA) 2011. Since then multiple studies have shown that DBT is effective in both mammography screening and diagnostic settings. As a result DBT has quickly emerged as a practice-changing standard that improves the clinical accuracy of a mammogram by increasing both sensitivity and specificity; thus, reducing the masking effect of overlapping fibroglandular tissue, thereby improving breast cancer detection. The improved accuracy and overall efficiency that DBT provides, will enhance radiologists’ performance and improve the patient experience.
To learn more and see the benefits of DBT in daily clinical practice we've developed an accredited educational program for online learning.
